These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 22158075

  • 21. Increased semaphorin 3c expression promotes tumor growth and metastasis in pancreatic ductal adenocarcinoma by activating the ERK1/2 signaling pathway.
    Xu X, Zhao Z, Guo S, Li J, Liu S, You Y, Ni B, Wang H, Bie P.
    Cancer Lett; 2017 Jul 01; 397():12-22. PubMed ID: 28315433
    [Abstract] [Full Text] [Related]

  • 22. Activation of c-jun N-terminal kinase is associated with cell proliferation and shorter relapse-free period in superficial spreading malignant melanoma.
    Jørgensen K, Davidson B, Flørenes VA.
    Mod Pathol; 2006 Nov 01; 19(11):1446-55. PubMed ID: 16951673
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Low RASSF6 expression in pancreatic ductal adenocarcinoma is associated with poor survival.
    Ye HL, Li DD, Lin Q, Zhou Y, Zhou QB, Zeng B, Fu ZQ, Gao WC, Liu YM, Chen RW, Li ZH, Chen RF.
    World J Gastroenterol; 2015 Jun 07; 21(21):6621-30. PubMed ID: 26074700
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Preoperative cognitive function predicts survival in patients with resectable pancreatic ductal adenocarcinoma.
    Baekelandt BM, Hjermstad MJ, Nordby T, Fagerland MW, Kure EH, Heiberg T, Buanes T, Labori KJ.
    HPB (Oxford); 2016 Mar 07; 18(3):247-54. PubMed ID: 27017164
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Tumor recurrence is independent of pancreatic fistula in patients after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
    Assifi MM, Zhang S, Leiby BE, Pequignot EC, Xia B, Rosato E, Lavu H, Kennedy EP, Yeo CJ, Berger AC.
    J Am Coll Surg; 2013 Oct 07; 217(4):621-7. PubMed ID: 23810574
    [Abstract] [Full Text] [Related]

  • 30. Failure patterns in resected pancreas adenocarcinoma: lack of predicted benefit to SMAD4 expression.
    Winter JM, Tang LH, Klimstra DS, Liu W, Linkov I, Brennan MF, DʼAngelica MI, DeMatteo RP, Fong Y, Jarnagin WR, Oʼreilly EM, Allen PJ.
    Ann Surg; 2013 Aug 07; 258(2):331-5. PubMed ID: 23360922
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Activated Akt and Erk expression and survival after surgery in pancreatic carcinoma.
    Chadha KS, Khoury T, Yu J, Black JD, Gibbs JF, Kuvshinoff BW, Tan D, Brattain MG, Javle MM.
    Ann Surg Oncol; 2006 Jul 07; 13(7):933-9. PubMed ID: 16788754
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Tumor size significantly correlates with postoperative liver metastases and COX-2 expression in patients with resectable pancreatic cancer.
    Matsumoto G, Muta M, Tsuruta K, Horiguchi S, Karasawa K, Okamoto A.
    Pancreatology; 2007 Jul 07; 7(2-3):167-73. PubMed ID: 17592230
    [Abstract] [Full Text] [Related]

  • 35. Stromal fibronectin expression in patients with resected pancreatic ductal adenocarcinoma.
    Hu D, Ansari D, Zhou Q, Sasor A, Said Hilmersson K, Andersson R.
    World J Surg Oncol; 2019 Feb 08; 17(1):29. PubMed ID: 30736807
    [Abstract] [Full Text] [Related]

  • 36. Overexpression of Raf-1 and ERK1/2 in sacral chordoma and association with tumor recurrence.
    Zhang K, Chen H, Zhang B, Sun J, Lu J, Chen K, Yang H.
    Int J Clin Exp Pathol; 2015 Feb 08; 8(1):608-14. PubMed ID: 25755752
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Treatment strategy for main duct intraductal papillary mucinous neoplasms of the pancreas based on the assessment of recurrence in the remnant pancreas after resection: a retrospective review.
    Tamura K, Ohtsuka T, Ideno N, Aso T, Shindo K, Aishima S, Ohuchida K, Takahata S, Ushijima Y, Ito T, Oda Y, Mizumoto K, Tanaka M.
    Ann Surg; 2014 Feb 08; 259(2):360-8. PubMed ID: 23989056
    [Abstract] [Full Text] [Related]

  • 40. Prognostic impact of cysteine proteases cathepsin B and cathepsin L in pancreatic adenocarcinoma.
    Niedergethmann M, Wostbrock B, Sturm JW, Willeke F, Post S, Hildenbrand R.
    Pancreas; 2004 Oct 08; 29(3):204-11. PubMed ID: 15367886
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.